SIBN SI-BONE Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SIBN

Price (delayed)

$14.2

Market cap

$583.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.13

Enterprise value

$588.84M

SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a ...

Highlights
The EPS rose by 37% YoY and by 5% QoQ
The company's revenue rose by 31% YoY and by 5% QoQ
The equity has soared by 72% YoY but it fell by 2.4% QoQ
SI-BONE's quick ratio has increased by 44% YoY but it has decreased by 17% QoQ
SI-BONE's gross margin has decreased by 8% YoY and by 3.3% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://si-bone.com
Peers: EQT

Key stats

What are the main financial stats of SIBN
Market
Shares outstanding
41.06M
Market cap
$583.12M
Enterprise value
$588.84M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.4
Price to sales (P/S)
3.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.24
Earnings
Revenue
$138.89M
EBIT
-$39.87M
EBITDA
-$34.45M
Free cash flow
-$26.51M
Per share
EPS
-$1.13
Free cash flow per share
-$0.69
Book value per share
$4.18
Revenue per share
$3.61
TBVPS
$6
Balance sheet
Total assets
$230.43M
Total liabilities
$61.05M
Debt
$38.99M
Equity
$169.38M
Working capital
$187.94M
Liquidity
Debt to equity
0.23
Current ratio
9.01
Quick ratio
8.01
Net debt/EBITDA
-0.17
Margins
EBITDA margin
-24.8%
Gross margin
78.8%
Net margin
-31.2%
Operating margin
-33.8%
Efficiency
Return on assets
-20.5%
Return on equity
-28.2%
Return on invested capital
-22.7%
Return on capital employed
-19.3%
Return on sales
-28.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SIBN stock price

How has the SI-BONE stock price performed over time
Intraday
-2.81%
1 week
-2.54%
1 month
-10.41%
1 year
-41.49%
YTD
-32.35%
QTD
-13.26%

Financial performance

How have SI-BONE's revenue and profit performed over time
Revenue
$138.89M
Gross profit
$109.42M
Operating income
-$46.93M
Net income
-$43.34M
Gross margin
78.8%
Net margin
-31.2%
SI-BONE's net margin has increased by 46% YoY and by 5% from the previous quarter
The company's operating margin rose by 40% YoY and by 2.3% QoQ
The company's revenue rose by 31% YoY and by 5% QoQ
SI-BONE's net income has increased by 29% YoY

Growth

What is SI-BONE's growth rate over time

Valuation

What is SI-BONE stock price valuation
P/E
N/A
P/B
3.4
P/S
3.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.24
The EPS rose by 37% YoY and by 5% QoQ
The equity has soared by 72% YoY but it fell by 2.4% QoQ
SIBN's P/B is 40% below its 5-year quarterly average of 5.7 and 40% below its last 4 quarters average of 5.7
The P/S is 50% less than the 5-year quarterly average of 7.8 and 40% less than the last 4 quarters average of 6.6
The company's revenue rose by 31% YoY and by 5% QoQ

Efficiency

How efficient is SI-BONE business performance
The ROE has soared by 50% YoY and by 12% from the previous quarter
The ROS rose by 48% YoY and by 6% QoQ
SI-BONE's ROA has increased by 45% YoY and by 9% from the previous quarter
The ROIC has grown by 37% YoY and by 8% from the previous quarter

Dividends

What is SIBN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SIBN.

Financial health

How did SI-BONE financials performed over time
SIBN's total assets is up by 46% year-on-year
SI-BONE's quick ratio has increased by 44% YoY but it has decreased by 17% QoQ
SI-BONE's debt is 77% less than its equity
The equity has soared by 72% YoY but it fell by 2.4% QoQ
The debt to equity has declined by 43% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.